Cargando…
Treatment of fresh human leukaemia cells with actinomycin D enhances their lysability by natural killer cells.
Human leukaemia cells isolated from peripheral blood were employed as targets for natural killer (NK) cells obtained from healthy donors and the effect of pretreatment of leukaemia cells with Actinomycin D on lysability was analysed in a chromium release assay. In 8/14 leukaemia cell samples a subst...
Autores principales: | Ziegler-Heitbrock, H. W., Erhardt, J., Riethmüller, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011504/ https://www.ncbi.nlm.nih.gov/pubmed/6626451 |
Ejemplares similares
-
Sex difference in clot lysability and association to coronary artery calcification
por: Ramanathan, Ramshanker, et al.
Publicado: (2018) -
Blastic natural killer cell lymphoma/leukaemia in a
cat
por: Hirabayashi, Miyuki, et al.
Publicado: (2019) -
ON THE DIFFERENTIAL CYTOTOXICITY OF ACTINOMYCIN D
por: Sawicki, Stanley G., et al.
Publicado: (1971) -
Fas-mediated cytotoxicity by freshly isolated natural killer cells
Publicado: (1995) -
In vitro and in silico evaluations of actinomycin X(2)and actinomycin D as potent anti-tuberculosis agents
por: Qureshi, Kamal Ahmad, et al.
Publicado: (2023)